Vanhaeverbeek M - Search Results

1

Van Meerhaeghe A, Vanhaeverbeek M. Van Meerhaeghe A, et al. Among authors: vanhaeverbeek m. Lancet Respir Med. 2013 Jul;1(5):e22-3. doi: 10.1016/S2213-2600(13)70115-2. Epub 2013 Jul 8. Lancet Respir Med. 2013. PMID: 24429209 No abstract available.

2

Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity C-reactive protein elevation.

Zouaoui Boudjeltia K, Van Meerhaeghe A, Doumit S, Guillaume M, Cauchie P, Brohée D, Vanhaeverbeek M, Kerkhofs M. Zouaoui Boudjeltia K, et al. Among authors: vanhaeverbeek m. Respiration. 2006;73(2):243-6. doi: 10.1159/000090201. Epub 2005 Dec 8. Respiration. 2006. PMID: 16549947

3

Oral pharmacologic treatment of type 2 diabetes mellitus.

Richard T, Brohee D, Van Meerhaeghe A, Vanhaeverbeek M. Richard T, et al. Among authors: vanhaeverbeek m. Ann Intern Med. 2012 Jul 3;157(1):76; author reply 76-7. doi: 10.7326/0003-4819-157-1-201207030-00018. Ann Intern Med. 2012. PMID: 22751769 No abstract available.

4

A new device to mimic intermittent hypoxia in mice.

Chodzyński KJ, Conotte S, Vanhamme L, Van Antwerpen P, Kerkhofs M, Legros JL, Vanhaeverbeek M, Van Meerhaeghe A, Coussement G, Boudjeltia KZ, Legrand A. Chodzyński KJ, et al. Among authors: vanhaeverbeek m. PLoS One. 2013;8(4):e59973. doi: 10.1371/journal.pone.0059973. Epub 2013 Apr 2. PLoS One. 2013. PMID: 23565179 Free PMC article.

5

Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men.

Boudjeltia KZ, Delporte C, Van Antwerpen P, Franck T, Serteyn D, Moguilevsky N, Raes M, Vanhamme L, Vanhaeverbeek M, Van Meerhaeghe A, Roumeguère T. Boudjeltia KZ, et al. Among authors: vanhaeverbeek m. Mediators Inflamm. 2013;2013:750742. doi: 10.1155/2013/750742. Epub 2013 Nov 18. Mediators Inflamm. 2013. PMID: 24347830 Free PMC article.

6

Acidic and neutral sialidase in the erythrocytes of patients with Type 2 diabetes: influence on erythrocyte lifespan.

Richard T, Boudjeltia KZ, Piagnerelli M, Vanhaeverbeek M. Richard T, et al. Among authors: vanhaeverbeek m. Blood. 2002 Aug 15;100(4):1511. doi: 10.1182/blood-2002-04-1072. Blood. 2002. PMID: 12184275 Free article. No abstract available.

7

Modifications of red blood cell shape and glycoproteins membrane content in septic patients.

Piagnerelli M, Boudjeltia KZ, Brohee D, Vincent JL, Vanhaeverbeek M. Piagnerelli M, et al. Among authors: vanhaeverbeek m. Adv Exp Med Biol. 2003;510:109-14. doi: 10.1007/978-1-4615-0205-0_18. Adv Exp Med Biol. 2003. PMID: 12580413 No abstract available.

8

Alterations of red blood cell shape and sialic acid membrane content in septic patients.

Piagnerelli M, Boudjeltia KZ, Brohee D, Piro P, Carlier E, Vincent JL, Lejeune P, Vanhaeverbeek M. Piagnerelli M, et al. Among authors: vanhaeverbeek m. Crit Care Med. 2003 Aug;31(8):2156-62. doi: 10.1097/01.CCM.0000079608.00875.14. Crit Care Med. 2003. PMID: 12973174

9

Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients?

Zouaoui Boudjeltia K, Piagnerelli M, Brohée D, Guillaume M, Cauchie P, Vincent JL, Remacle C, Bouckaert Y, Vanhaeverbeek M. Zouaoui Boudjeltia K, et al. Among authors: vanhaeverbeek m. Thromb J. 2004 Sep 30;2(1):7. doi: 10.1186/1477-9560-2-7. Thromb J. 2004. PMID: 15456513 Free PMC article.

10

Rapid alterations in transferrin sialylation during sepsis.

Piagnerelli M, Boudjeltia KZ, Nuyens V, De Backer D, Su F, Wang Z, Vincent JL, Vanhaeverbeek M. Piagnerelli M, et al. Among authors: vanhaeverbeek m. Shock. 2005 Jul;24(1):48-52. doi: 10.1097/01.shk.0000168524.20588.67. Shock. 2005. PMID: 15988320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page